Cooper Companies to acquire Sauflon, CooperVision partners with Turkish university

Article

The Cooper Companies, Inc. announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals for approximately $1.2 billion. Sauflon forecasts revenue of approximately $210 million for its fiscal year ending October 31, 2014, up approximately 22 percent year-over-year.

Pleasanton, CA-The Cooper Companies, Inc. announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals for approximately $1.2 billion. Sauflon forecasts revenue of approximately $210 million for its fiscal year ending October 31, 2014, up approximately 22 percent year-over-year.

The transaction is subject to regulatory approval and is anticipated to close prior to the company’s fiscal year end, October 31, 2014.

“We are extremely pleased to announce this acquisition which gives CooperVision the world's most comprehensive portfolio of daily disposable lenses,” says Robert S. Weiss, Cooper's president and chief executive officer. “CooperVision will now be able to offer a multi-tier daily strategy that includes a full suite of silicone hydrogel and hydrogel lenses, including options within all categories-spheres, torics, and multifocals. The daily segment is the fastest growing segment of the soft contact lens market and this transaction positions CooperVision as the premier company in this space.”

In related news, CooperVision recently partnered with Bogazici University’s College of Business in Istanbul, Turkey, to focus on developing its next generation of global leaders. As a component of the company’s Inspirational Leadership Program, a select group of senior leaders spent five days on campus earlier this year, immersing themselves in issues relating to entrepreneurship, governance, national culture and institutions, financial management and growing a high-caliber, emerging market workforce.

Bogazici University is ranked among the world’s top 200 institutions of higher education. Its dynamic faculty is internationally respected and globally connected, and highly able to share experiences and insights regarding the dynamic and sometimes volatile nature of multinational business challenges and opportunities.

Recent Videos
Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO
Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO
EyeCon Co-chair Oluwatosin U. Smith, MD talks passion for research and education in ophthalmology
Eyerie Academics cofounders discuss the organization's future and preparing optometric students
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Sherrol A. Reynolds, OD, speaks about highlights from the 2024 NOA Convention
A. Philip Aitsebaomo, O.D., Ph.D. outlines his talk on treating patients with prosthetic eyes
© 2024 MJH Life Sciences

All rights reserved.